M. Bellet Ezquerra

SEOM clinical guidelines in advanced and recurrent breast cancer (2018)

Mafalda Oliveira, S. López-Tarruella Cobo, J. Gavilá Gregori, 2019, Clinical and Translational Oncology.

SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer

A. Prat, P. Villagrasa, B. González-Farré, 2021, Frontiers in Oncology.

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial

Miguel Martín, J. R. De la Haba-Rodríguez, S. González-Santiago, 2022, Breast.

SEOM clinical guidelines for the treatment of metastatic breast cancer

D. Isla Casado, L. Calvo Martínez, A. Rodríguez Lescure, 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.